Healthcare -
Biotechnology - NASDAQ - US
$ 19.14
-1.8 %
$ 1.36 B
Market Cap
-6.6
P/E
NRIX - COST OF REVENUE
Cost of Revenue NRIX - Nurix Therapeutics, Inc.
189 M
LAST VALUE
457.67%
2 YEAR CAGR
36.09%
5 YEAR CAGR
0.00%
10 YEAR CAGR